Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KYLIE A MONEY

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1871058131
CMS profile
10438010
Location
OGDEN, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$5,096.02

166 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,892.28 156
Travel and Lodging $823.80 5
Long term medical supply or device loan $299.10 3
Education $80.84 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $1,623.13 27
AstraZeneca Pharmaceuticals LP $278.58 9
GENZYME CORPORATION $255.89 5
Janssen Biotech, Inc. $252.70 8
Astellas Pharma US Inc $177.84 7
Daiichi Sankyo Inc. $172.11 9
BeiGene USA, Inc. $162.49 5
Merck Sharp & Dohme LLC $151.23 8
Lilly USA, LLC $138.24 8
Incyte Corporation $119.76 4
Seagen Inc. $113.14 4
Myriad Women's Health, Inc. $112.06 2
Pharmacyclics LLC, An AbbVie Company $107.88 5
Genmab U.S., Inc. $106.14 4
Genentech USA, Inc. $104.06 3
Celgene Corporation $96.13 5
ABBVIE INC. $87.63 4
Regeneron Healthcare Solutions, Inc. $87.13 4
GlaxoSmithKline, LLC. $79.98 3
Amneal Pharmaceuticals LLC $79.24 4
EMD Serono, Inc. $68.61 4
Organon LLC $66.19 4
Amgen Inc. $61.18 2
Boehringer Ingelheim Pharmaceuticals, Inc. $57.97 2
Eisai Inc. $44.12 2
TerSera Therapeutics LLC $39.79 2
Sumitomo Pharma America, Inc. $38.09 2
PFIZER INC. $34.68 2
Blueprint Medicines Corporation $32.79 1
JAZZ PHARMACEUTICALS INC. $30.39 2
ARRAY BIOPHARMA INC $26.78 1
PharmaEssentia USA Corporation $26.04 1
ACCORD HEALTHCARE, INC. $24.61 1
Takeda Pharmaceuticals U.S.A., Inc. $24.30 1
TAIHO ONCOLOGY, INC. $24.02 1
Kite Pharma, Inc. $22.94 1
Deciphera Pharmaceuticals Inc. $22.74 1
Exelixis Inc. $22.73 1
Coherus Biosciences Inc. $21.42 1
Foundation Medicine, Inc. $18.43 1
Pharmacosmos Therapeutics Inc. $18.20 1
Mirati Therapeutics, Inc. $17.44 1
MorphoSys, US Inc. $16.45 1
RECORDATI_RARE_DISEASES_INC. $15.82 1
E.R. Squibb & Sons, L.L.C. $14.93 1

Page 2 of 4; records 51–100 of 166 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KYLIE A MONEY

NPI 1871058131 · CMS profile ID 10438010

Physician Assistants & Advanced Practice Nursing Providers / Physician Assistant

OGDEN, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 166 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1871058131?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KYLIE A MONEY, NPI 1871058131, CMS profile ID 10438010. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 166 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1871058131?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). KYLIE A MONEY, NPI 1871058131, CMS profile ID 10438010. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 166 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1871058131?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
KYLIE A MONEY, NPI 1871058131, CMS profile ID 10438010, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 166 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1871058131?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

166 matching records · $5,096.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 166 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 166.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $21.4810/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050428701 CMS
Novartis Pharmaceuticals Corporation $2.8410/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822085 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.8810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996713551 CMS
Janssen Biotech, Inc. $21.7910/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754551 CMS
Mirati Therapeutics, Inc. $17.4409/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058013873 CMS
ABBVIE INC. $24.1909/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006247039 CMS
GENZYME CORPORATION $87.9009/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050428715 CMS
Daiichi Sankyo Inc. $28.5709/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006494427 CMS
AstraZeneca Pharmaceuticals LP $19.6209/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011327437 CMS
MorphoSys, US Inc. $16.4509/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060329135 CMS
Regeneron Healthcare Solutions, Inc. $28.9109/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999806039 CMS
RECORDATI_RARE_DISEASES_INC. $15.8209/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060357715 CMS
TerSera Therapeutics LLC $15.1709/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052434265 CMS
Genmab U.S., Inc. $22.4309/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051352553 CMS
Incyte Corporation $14.8209/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044629437 CMS
Celgene Corporation $18.0909/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016133109 CMS
TerSera Therapeutics LLC $24.6209/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052434261 CMS
GENZYME CORPORATION $26.5408/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050428647 CMS
Eisai Inc. $23.9808/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023350781 CMS
Merck Sharp & Dohme LLC $13.0108/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048572005 CMS
AstraZeneca Pharmaceuticals LP $24.3408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012098061 CMS
Janssen Biotech, Inc. $19.0408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754559 CMS
Novartis Pharmaceuticals Corporation $14.0708/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822081 CMS
Coherus Biosciences Inc. $21.4208/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060237393 CMS
ABBVIE INC. $28.1208/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006247037 CMS
Regeneron Healthcare Solutions, Inc. $14.2508/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999806031 CMS
Sumitomo Pharma America, Inc. $17.9408/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031093045 CMS
Genentech USA, Inc. $34.9008/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040668551 CMS
Janssen Biotech, Inc. $10.6508/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754555 CMS
AstraZeneca Pharmaceuticals LP $19.5108/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014384499 CMS
BeiGene USA, Inc. $20.7608/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051195457 CMS
Celgene Corporation $19.9808/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016133103 CMS
Amneal Pharmaceuticals LLC $24.8008/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053577803 CMS
Novartis Pharmaceuticals Corporation $18.2707/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822073 CMS
EMD Serono, Inc. $17.5907/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032319057 CMS
Pharmacyclics LLC, An AbbVie Company $22.7007/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998306617 CMS
Pharmacosmos Therapeutics Inc. $18.2007/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046278883 CMS
Astellas Pharma US Inc $69.9907/18/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034297119 CMS
Lilly USA, LLC $21.4307/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033166903 CMS
Incyte Corporation $19.1407/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044629401 CMS
Janssen Biotech, Inc. $10.2407/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754557 CMS
Seagen Inc. $16.5407/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995831357 CMS
Genmab U.S., Inc. $24.3007/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051352545 CMS
Novartis Pharmaceuticals Corporation $21.0906/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822061 CMS
Novartis Pharmaceuticals Corporation $11.4806/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822065 CMS
Novartis Pharmaceuticals Corporation $0.7906/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992822069 CMS
Astellas Pharma US Inc $23.3406/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034222441 CMS
Foundation Medicine, Inc. $18.4306/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058798965 CMS
AstraZeneca Pharmaceuticals LP $15.3306/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014863101 CMS
Seagen Inc. $59.6006/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995831403 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $2,104.24 89
PY2022 $4,313.44 127
PY2023 $5,096.02 166
PY2024 $8,150.97 217
PY2025 $4,850.91 164

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,653.05 14
PY2024 Recipient $2,673.55 17

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient ABBVIE INC. $48.00 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403080
Recipient ABBVIE INC. $25.00 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403085
Recipient ABBVIE INC. $520.38 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403089
Recipient ABBVIE INC. $47.37 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403094
Recipient ABBVIE INC. $24.00 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403098
Recipient ABBVIE INC. $28.70 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403102
Recipient ABBVIE INC. $79.00 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403105
Recipient ABBVIE INC. $117.82 05/30/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403110
Recipient ABBVIE INC. $392.12 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403057
Recipient ABBVIE INC. $144.91 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403061
Recipient ABBVIE INC. $48.71 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403064
Recipient ABBVIE INC. $26.60 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403067
Recipient ABBVIE INC. $124.78 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403071
Recipient ABBVIE INC. $25.66 05/29/2025 Covered Recipient Non-Physician Practitioner A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202403077